BIO-CAT Enzymes & Microbials acquired by Lallemand Inc.
Lallemand Inc. acquired BIO-CAT Enzymes & Microbials, an US health ingredients brand. Financial terms were not publicly disclosed. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- BIO-CAT Enzymes & Microbials
- Acquirer
- Lallemand Inc.
- Seller
- -
- Announced
- -
- Geography
- United States
- Tags
- Dietary SupplementsEnzymesHealth IngredientsHealthcareMicrobial IngredientsProbiotics
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-08-08
- Latest update
- 2026-08-08
Value and multiples
Price / value
Undisclosed
Transaction value
Basis: FundComb estimate
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Financial terms were not disclosed in the public sources reviewed.
Source summary
Lallemand boosts U.S. footprint and capacity with BIO-CAT acquisition
ConfirmedNutraIngredients reported that Lallemand Inc. completed its acquisition of U.S.-based BIO-CAT Enzymes & Microbials effective July 31, 2026. BIO-CAT provides enzyme blends, probiotics, and microbial solutions, and the transaction terms were undisclosed.
Open source